Novartis Says Experimental Drug Quells Gout Attacks, Pain
This article is for subscribers only.
Novartis AG said that an experimental antibody relieved pain and stopped new attacks of gout better than a steroid injection in two advanced studies.
The company reported results from clinical trials on more than 450 patients who didn’t benefit from medicines like non-steroidal anti-inflammatory drugs or couldn’t take them, Basel, Switzerland-based Novartis said in an e-mailed statement today.